Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (171-180 of 418) with videos related to

Pageof 42
Sort By:
The Journal of Investigative Dermatology|January 18, 2006
Pseudoxanthoma elasticum is a recessive disease characterized by compound heterozygosityFranziska Ringpfeil, Kelly McGuigan, Lauren Fuchsel, et al.
Dermatology Online Journal|June 17, 2025
Risks of topical corticosteroid therapy and role for advanced targeted topical treatments for inflammatory skin diseases: an expert consensus panelJoshua Burshtein, Raj Chovatiya, Alexandra Golant, et al.
JAMA Dermatology|April 5, 2013
Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratosesMark Lebwohl, Stephen Shumack, Linda Stein Gold, et al.
Photochemistry and Photobiology|May 8, 2003
The combination of benzo[a]pyrene and ultraviolet A causes an in vivo time-related accumulation of DNA damage in mouse skinRao Saladi, Lisa Austin, Dayuan Gao, et al.
Journal of the American Academy of Dermatology|February 3, 2020
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trialDavid M Pariser, Jerry Bagel, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|October 17, 2022
The reliability of disease severity assessment in psoriasis patients of color: Results of an educational interventionStephanie von Csiky-Sessoms, Joel Correa Da Rosa, Joseph Han, et al.
International Journal of Dermatology|October 21, 2020
Treatment of COVID-19 induced chilblains with topical nitroglycerinMark Weingarten, Brian Abittan, Ryan Rivera-Oyola, et al.
Journal of Psoriasis and Psoriatic Arthritis|June 2, 2025
All-Cause Mortality is Higher in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General Population: A US-Based Claims AnalysisAlice B Gottlieb, Hannah Crooke Kwiatkowski, Juan Semeco, et al.
The Journal of Investigative Dermatology|August 12, 2004
Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatologyMary M Prendergast, William Abramovits, Mark Boguniewicz, et al.
Journal of Drugs in Dermatology : JDD|August 20, 2019
Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis RegistryLauren Bonomo, Brian J. Abittan, Peter W. Hashim, et al.
Pageof 42

Showing results (171-180 of 418) with videos related to

Sort By:
Pageof 42
The Journal of Investigative Dermatology|January 18, 2006
Pseudoxanthoma elasticum is a recessive disease characterized by compound heterozygosityFranziska Ringpfeil, Kelly McGuigan, Lauren Fuchsel, et al.
Dermatology Online Journal|June 17, 2025
Risks of topical corticosteroid therapy and role for advanced targeted topical treatments for inflammatory skin diseases: an expert consensus panelJoshua Burshtein, Raj Chovatiya, Alexandra Golant, et al.
JAMA Dermatology|April 5, 2013
Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratosesMark Lebwohl, Stephen Shumack, Linda Stein Gold, et al.
Photochemistry and Photobiology|May 8, 2003
The combination of benzo[a]pyrene and ultraviolet A causes an in vivo time-related accumulation of DNA damage in mouse skinRao Saladi, Lisa Austin, Dayuan Gao, et al.
Journal of the American Academy of Dermatology|February 3, 2020
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trialDavid M Pariser, Jerry Bagel, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|October 17, 2022
The reliability of disease severity assessment in psoriasis patients of color: Results of an educational interventionStephanie von Csiky-Sessoms, Joel Correa Da Rosa, Joseph Han, et al.
International Journal of Dermatology|October 21, 2020
Treatment of COVID-19 induced chilblains with topical nitroglycerinMark Weingarten, Brian Abittan, Ryan Rivera-Oyola, et al.
Journal of Psoriasis and Psoriatic Arthritis|June 2, 2025
All-Cause Mortality is Higher in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General Population: A US-Based Claims AnalysisAlice B Gottlieb, Hannah Crooke Kwiatkowski, Juan Semeco, et al.
The Journal of Investigative Dermatology|August 12, 2004
Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatologyMary M Prendergast, William Abramovits, Mark Boguniewicz, et al.
Journal of Drugs in Dermatology : JDD|August 20, 2019
Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis RegistryLauren Bonomo, Brian J. Abittan, Peter W. Hashim, et al.
Pageof 42